Compare Fluxion Biosciences vs Gentronix Limited
Customers evaluate the quality of Fluxion Biosciences's products using the following success metrics.
Overview
Fluxion Biosciences is 19 yrs old and is based in United States.
Fluxion Biosciences produces automated patch clamp technology and cell-based assay tools. Its products include ERASE-Seq for next-generation sequencing (NGS) analysis of cancer from a "liquid biopsy" blood sample, IsoFlux for circulating tumor cell analysis, and more. It was founded in 2005 and is based in Oakland, California. In August 2023, Fluxion Biosciences was acquired by Cell Microsystems. The terms of the transaction were not disclosed.
Gentronix Limited is 25 yrs old and is based in United Kingdom.
Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products. The company enables major global brands to perform hazard and safety assessments, from early-stage discovery through to regulatory submission and approval.
Demo Video
Leadership
Michelle Khine (Founder)
Richard Walmsley (Founder)
Investors
Cell Microsystems, Paycheck Protection Program
Mercia Asset Management, Manchester Technology Fund
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Fluxion Biosciences has not claimed their profile.
Work for Fluxion Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Fluxion Biosciences?
Claim your profile now.
Information not available because Gentronix Limited has not claimed their profile.
Work for Gentronix Limited? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Gentronix Limited?
Claim your profile now.